What is the most recent earnings date for USNA stock?
USANA HEALTH SCIENCES INC (USNA) last reported earnings on 2/17/2026.
NYSE:USNA • US90328M1071
Past quarterly earnings results for USANA HEALTH SCIENCES INC (USNA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.60 | 0.42 | 43.47% | -6.25% | 226.2M | 230.48M | -1.86% | 5.89% |
| Q3 2025 | -0.15 | 0.48 | -131.29% | -126.79% | 214M | 228.61M | -6.39% | 6.88% |
| Q2 2025 | 0.74 | 0.55 | 34.35% | 37.04% | 236M | 229.7M | 2.74% | 10.87% |
| Q1 2025 | 0.73 | 0.71 | 2.24% | -15.12% | 249.539M | 247.9M | 0.66% | 9.54% |
| Q4 2024 | 0.64 | 0.50 | 28.18% | -26.44% | 213.613M | 213.02M | 0.28% | -3.38% |
| Q3 2024 | 0.56 | 0.49 | 13.20% | -5.08% | 200.221M | 209.89M | -4.61% | -6.16% |
| Q2 2024 | 0.54 | 0.66 | -18.68% | -39.33% | 212.869M | 225.41M | -5.56% | -10.64% |
| Q1 2024 | 0.86 | 0.70 | 22.37% | -9.47% | 227.8M | 231.39M | -1.55% | -8.29% |
| Q4 2023 | 0.87 | 0.53 | 65.46% | 31.82% | 221.083M | 216.65M | 2.05% | -3.03% |
| Q3 2023 | 0.59 | 0.65 | -9.12% | -24.36% | 213.365M | 224.81M | -5.09% | -8.54% |
| Q2 2023 | 0.89 | 0.71 | 25.46% | -11.00% | 238.202M | 235.77M | 1.03% | -9.94% |
| Q1 2023 | 0.95 | 0.78 | 21.59% | -17.39% | 248.4M | 245.03M | 1.38% | -8.98% |
| Q4 2022 | 0.66 | 0.36 | 83.30% | -35.92% | 228M | 207.86M | 9.69% | -14.70% |
| Q3 2022 | 0.78 | 0.91 | -13.98% | -42.65% | 233.3M | 249.08M | -6.34% | -14.98% |
| Q2 2022 | 1.00 | 1.16 | -13.62% | -46.52% | 264.5M | 273.82M | -3.40% | -21.47% |
| Q1 2022 | 1.15 | 1.16 | -1.10% | -20.69% | 272.9M | 272.66M | 0.09% | -11.40% |
| Q4 2021 | 1.03 | 1.31 | -21.11% | -44.92% | 267.3M | 277.37M | -3.63% | -13.91% |
| Q3 2021 | 1.36 | 1.33 | 2.56% | -5.56% | 274.4M | 273.43M | 0.35% | -8.07% |
| Q2 2021 | 1.87 | 1.75 | 6.90% | 41.67% | 336.8M | 339.27M | -0.73% | 30.04% |
| Q1 2021 | 1.45 | 1.51 | -4.27% | 17.89% | 308M | 307.5M | 0.16% | 15.53% |
| Q4 2020 | 1.87 | 1.46 | 28.50% | - | 310.5M | 297.37M | 4.42% | - |
| Q3 2020 | 1.44 | 1.29 | 11.60% | - | 298.5M | 284.38M | 4.97% | - |
| Q2 2020 | 1.32 | 1.10 | 19.83% | - | 259M | 261.46M | -0.94% | - |
| Q1 2020 | 1.23 | 0.85 | 44.42% | - | 266.6M | 245.49M | 8.60% | - |
Notes
USANA HEALTH SCIENCES INC (USNA) last reported earnings on 2/17/2026.
USANA HEALTH SCIENCES INC (USNA) beat EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, USANA HEALTH SCIENCES INC (USNA) has beaten EPS estimates in 3 out of 4 releases.